What is PocDoc?
PocDoc is at the forefront of digital health innovation, developing a platform that empowers individuals to test for a wide range of major diseases and conditions using just a smartphone or tablet and a fingerprick of blood. The platform provides a comprehensive health assessment, contextualizing results and offering tailored solutions for identified health issues. PocDoc's proprietary quantitative blood tests are primarily focused on preventative areas such as Cardiovascular Disease and Diabetes, with the capability to integrate existing rapid tests for digitized results and subsequent care pathways. The company demonstrated its platform's utility during the pandemic by partnering with NHS Digital and the Department of Health for smartphone-based COVID-19 testing, and has also collaborated with PATH to support polio eradication efforts in remote areas.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.2M across 1 funding round:
Other Financing Round
$6.2M
Other Financing Round (2024): $6.2M with participation from MMC Ventures, Simplyhealth Group, and Draper Esprit
Key Investors in PocDoc
MMC Ventures
MMC Ventures is a venture capital firm that focuses on funding and scaling technology companies, with a specialization in early-stage investments from Seed to Series A.
Simplyhealth Group
Simplyhealth Group is a leading provider of everyday health products and services, dedicated to helping individuals manage their health needs and make the most of life since 1872.
Draper Esprit
Draper Esprit is a venture capital firm that invests in high-growth technology companies with global ambitions, operating across London, Cambridge, and Dublin.
What's next for PocDoc?
With this major enterprise-level funding, PocDoc is poised for significant expansion and further development of its innovative digital health solutions. The strategic investment signals strong confidence in the company's vision and its potential to disrupt traditional diagnostic methods. Future growth is expected to focus on scaling its platform, expanding its test offerings, and forging new partnerships to reach a broader global audience, particularly in preventative healthcare and disease management.
See full PocDoc company page
